Minutes - Medication WG 2021-05-11

Attendees

• Bruno Casneuf
• Dieter Sauvillers
• Elhassan Baazizi
• Hanne Vuegen
• Jean-Louis Maggetto
• Jean-Michel Polfliet
• Jens Penny
• José Costa Teixeira
• Karlien Erauw
• Pablo Christiaens
• Richard Francken
• Robin Bosman
• Tom De Backer
• Tom Henkens
• Will van Norel

Excused/Not present

• Anne Nerenhausen
• Annemieke Vergauwe
• Jan Lenie
• Jeroen De Wilde
• Lars Vanreppelen
• Marc Buckens
• Nils Devos

Agenda

• feedback on the model

Minutes

• Magistral preparations: no update
• What is the purpose and intent of the high level modelling towards the scope of the medication scheme project and exchange of the related MS information, including the outcome

• the purpose of the logical model is having a common understanding what the data means apart from the FHIR modelling
• logical model is perceived as a flow

• What do we want to achieve here ? the MS, the careplan, ...

• the purpose is to achieve the MS
• are we going to translate kmehr to FHIR ? lots of risks
• starting from something completely new: we risk to lose data from the past, we need compatibility

can the care plan be left out from this WG ?

• We miss the definition of the MS

• currently the MS in kmehr is visualised in a document
• MS can be the scheme for Vitalink
• there is a type/version

• What if an indication/treatment is confidential to one GP, one pharmacist will know of the dipsense of the medication without the indication, what about sharing to the vault

• will it be shared to the vault? mechanisms will have to be put in place
• permission resource will have to be added

• medication treatment vs medication summary vs medication scheme: there is a lack of detail in the modelling

• medication summary : sort of a view/snapshot on the medication
• medication scheme: digested scheme of a patient's medications

• kmehr MS with a concept of different medication treatments: what contains the list of medication treatment lines ? the medication treatment

• There is a need for examples and compilation to documents
• Therefore it would be useful to start a list with the examples that we need

• psychiatric medication with privacy settings
• medication having same substance used for different indications and different posologies
• distinction between hospital treatment and home therapy
• interactions between home therapy and psychiatric medication
• magistral preparations
• need to see clear example of and difference b/w treatments and summary

• Do we need support from pharmacist ?

• José will ask input from vidis
• Pablo will have a look
• Jens will try to provide input
• Tom H will check

Action items for next meeting

• each one of us to check offline and with his team to continue discussion on treatment lines
• status of approval of medication history : to provide by HL7 Belgium

Next meeting May 25 at 11AM